Cost-effectiveness of Alzheimer’s disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis
José Contador, Ana Magdalena Vargas‐Martínez, Raquel Sánchez‐Valle, Marta Trapero‐Bertran, Albert Lladó
Topics & Concepts
MedicineCognitive impairmentAlzheimer's diseaseDiseaseAmyloid (mycology)Amyloid βOncologyNeurosciencePsychologyInternal medicinePathologyDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsHealth Systems, Economic Evaluations, Quality of Life